Over-the-counter pill boosts access to contraception, OHSU study finds
Nationwide study documents 31% percentage point increase in people shifting from no birth control to the over-the-counter oral contraceptive.
Health Care
More Health Care Stories
- Latest Stories
OHSU, GE Healthcare team up to explore new frontiers in health care innovation
November 13, 2015
Oregon Health & Science University and GE Healthcare have signed a memorandum of understanding to develop collaborative research programs in cardiovascular medicine, imaging and big data research. The research programs are aimed at bringing together OHSU’s clinical expertise with GE Healthcare’s technology prowess to answer fundamental questions in biology and medicine.
Oregon Health & Science University and Salem Health affiliation officially launches
November 10, 2015
Oregon Health & Science University and Salem Health have finalized an agreement to manage their respective clinical services as an integrated health system. The agreement creates OHSU Partners, a joint management company that will officially become operational on Monday, Nov. 16.
What really makes cancer drug ‘super responders’ exceptional survival stories?
November 09, 2015
Reports of “super responders” – patients who do exceptionally well on a cancer treatment –may be driving unfounded assumptions about the effectiveness of the drugs involved, researchers caution.
OHSU statement regarding its investment in health care transformation
November 06, 2015
In December 2014, OHSU agreed to lend Moda Health Plan $50 million to support its ongoing participation in the health care exchange. The loan is in the form of a surplus note — a common financial instrument in the insurance industry to provide capital.
Bay Area Cancer Center first to join OHSU Knight Cancer Network
October 31, 2015
Bay Area Hospital and the OHSU Knight Cancer Institute have agreed to launch the first site of the newly formed OHSU Knight Cancer Network at the Bay Area Cancer Center in Coos Bay, Oregon.
Media’s frequent use of superlative terms to describe new cancer drugs questioned by study
October 29, 2015
An analysis of media coverage published in JAMA Oncology finds that the use of superlative terms to describe new cancer drugs is commonplace even when the drugs show only modest benefits or there is still a lack of clinical data to support enthusiastic statements.
Fall, Halloween safety tips from OHSU Doernbecher and the Oregon Poison Center
October 27, 2015
As colorful leaves fall from the trees and the air turns cool and crisp, it is important to remember that the fall season can pose some safety risks.
OHSU releases Mole Mapper ResearchKit app to track potential skin cancers
October 14, 2015
Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.
Immunovia, OHSU collaborating on early detection test for pancreatic cancer
October 04, 2015
Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University (OHSU) formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient’s immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types.
Got drugs? OHSU hosts prescription drug ‘take-back’ event Sept. 26
September 10, 2015
OHSU invites the public to safely and responsibly dispose of unused or expired prescription medications as part of the Drug Enforcement Administration’s National Take-Back Initiative, which aims to provide a safe, convenient, and ...